Barbara Y. Chan
Directeur Financier/CFO chez OMEGA THERAPEUTICS, INC.
Postes actifs de Barbara Y. Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
OMEGA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 31/05/2024 | - |
Directeur Financier/CFO | 31/05/2024 | - | |
Corporate Officer/Principal | - | 31/05/2024 |
Historique de carrière de Barbara Y. Chan
Anciens postes connus de Barbara Y. Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
NOVELION THERAPEUTICS INC. | Comptroller/Controller/Auditor | - | 24/09/2019 |
AEGERION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - | - |
President | - | - |
Formation de Barbara Y. Chan
Bentley University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Canada | 2 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
President | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OMEGA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Barbara Y. Chan
- Expérience